Asia Pacific Medical Device Coating Market Outlook to 2028

Asia Pacific Medical Device Coating Market Overview

Asia Pacific Medical Device Coating Market was valued at USD 2 billion in 2023, driven primarily by the increasing demand for minimally invasive procedures and the rising prevalence of chronic diseases like diabetes and cardiovascular disorders. The growth is also fueled by advancements in coating technologies that enhance the functionality and biocompatibility of medical devices, ensuring better patient outcomes and longer device life spans.

Major players in the Asia Pacific Medical Device Coating Market include companies like DSM Biomedical, Covalon Technologies Ltd., AST Products Inc., Biocoat Inc., and Hydromer Inc. These companies have established strong market positions due to their innovative product offerings, extensive R&D activities, and strategic partnerships with healthcare providers.

In 2023, DSM Biomedical has rebranded its UHMWPE portfolio to Ulteeva Purity, which includes fibers, membranes, and powders known for their strength and durability. These materials are essential for various medical applications, including orthopedic devices.

Cities like Beijing, Tokyo, and Seoul dominated the Asia Pacific Medical Device Coating Market. Beijings dominance is attributed to its robust healthcare infrastructure, significant government investment in medical research, and a high concentration of medical device manufacturers. Tokyo and Seoul also play key roles due to their advanced technological capabilities and the presence of numerous healthcare facilities that utilize coated medical devices extensively.

Asia Pacific Medical Device Coating Market Size

Table for Dev.

Asia Pacific Medical Device Coating Market Size (in USD Bn), 2018-2028

Year

Market Size (in USD Bn)

CAGR (in %) 2018-2023

CAGR (in %) 2023-2028

2018

XX

20232

XX%

Source: https://www.businessmarketinsights.com/reports/asia-pacific-medical-device-coating-market

Asia Pacific Medical Device Coating Market Segmentation

The Asia Pacific Medical Device Coating Market can be segmented based on several factors:

By Coating Type: Asia Pacific Medical Device Coating Market is segmented by coating type into hydrophilic coatings, antimicrobial coatings, drug-eluting coatings, and others. In 2023, hydrophilic coatings dominated this segment due to their widespread application in catheters and guidewires, which are essential in minimally invasive procedures. The hydrophilic properties reduce friction and improve patient comfort, making these coatings highly popular among healthcare professionals.

Coating Type

Market Share (2023)

Hydrophilic Coatings

40%

Antimicrobial Coatings

25%

Drug-Eluting Coatings

20%

Others

15%

By Application: Asia Pacific Medical Device Coating market is segmented by application into cardiovascular devices, orthopedics, neurology, general surgery, and others. Cardiovascular devices dominated this segment in 2023, driven by the high incidence of cardiovascular diseases and the increasing number of coronary and peripheral interventions. Coated cardiovascular devices enhance performance by preventing thrombosis and improving biocompatibility, leading to their extensive adoption.

Application

Market Share (2023)

Cardiovascular Devices

35%

Orthopedics

25%

Neurology

20%

General Surgery

10%

Others

5%

By Region: Asia Pacific Medical Device Coating Market is segmented by region into China, South Korea, India, Japan, Australia, and the rest of APAC. In 2023, China dominated the market due to its large population base, increasing healthcare expenditure, and significant investments in medical technology advancements. The presence of numerous domestic manufacturers also contributes to China's leading position in the region.

Asia Pacific Medical Device Coating Market Competitive Landscape

Company Name

Establishment Year

Headquarters

DSM Biomedical

1987

Geleen, Netherlands

Covalon Technologies Ltd.

2004

Ontario, Canada

AST Products Inc.

1989

Billerica, USA

Biocoat Inc.

1991

Horsham, USA

Hydromer Inc.

1980

Branchburg, USA

Hydromer: In 2024, Hydromer announced the launch of its new Hydro Thromb X medical device coating technology. This product is designed to be thromboresistant and is compliant with European Union regulations, making it suitable for marketing in the Asia-Pacific region. The launch aims to enhance patient safety and clinical outcomes, which is crucial for partnerships with medical device manufacturers in the area.

Covalon Technologies Ltd.: In 2023, Harland Medical Systems announced the opening of a new office in Caesarea, Israel. This strategic expansion aims to enhance the company's global operations and improve customer service, particularly in the Asia Pacific medical device coatings market. This move follows the company's previous establishment of a European headquarters in Cork, Ireland, further solidifying its international presence in the medical device coatings sector.

Asia Pacific Medical Device Coating Industry Analysis

Growth Drivers:

Increasing Prevalence of Chronic Diseases and Surgical Procedures: Asia Pacific region has witnessed a significant rise in chronic diseases, such as cardiovascular disorders and diabetes, which has led to an increased demand for medical devices that require advanced coatings. Cardiovascular diseases are responsible for approximately 62% of all deaths in the South-East Asia region, equating to around 9 million deaths annually due to noncommunicable diseases (NCDs).

Advancements in Coating Technologies: Technological advancements in medical device coatings have significantly contributed to market growth. The demand for specialized coatings, such as drug-eluting coatings, has surged, particularly in cardiovascular and orthopedic applications. These coatings release therapeutic agents to enhance patient outcomes, reflecting a shift towards more personalized medical treatments.

Growth in Healthcare Infrastructure and Expenditure: The Asia Pacific region has seen considerable growth in healthcare infrastructure, with countries like India, China, and Indonesia leading in terms of new hospital constructions and healthcare facilities. For instance, Kindai University Hospital, Osaka, Japan is a significant project valued at $530 million is underway, with a completion date set for Q3 2025. This increased expenditure on healthcare infrastructure has led to higher demand for coated medical devices, thereby driving market growth.

Challenges
:

Stringent Regulatory Environment: Asia Pacific medical device coating market faces challenges due to stringent regulatory requirements and compliance issues across different countries. For instance, the China National Medical Products Administration (NMPA) implemented new guidelines requiring all medical devices with coatings to undergo additional testing for biocompatibility and chemical safety, increasing the time and cost of getting products to market.

Lack of Standardization Across the Region: The lack of standardization in medical device coatings across the Asia Pacific region poses a significant challenge for manufacturers. Different countries have varying standards and requirements for medical device coatings, making it difficult for companies to develop products that can be universally accepted. This lack of harmonization not only increases costs but also delays the time to market for new products, impacting the overall growth of the market

 Government Initiatives:

China's Healthy China 2030 Plan: Healthy China 2030 plan, initiated by the Chinese government in October 2016, represents a comprehensive strategy aimed at enhancing the health of the population and integrating health considerations into socio-economic development. Under this initiative in 2023, collaborative efforts involved the Johnson & Johnson Foundation and the International Health Exchange and Cooperation Centre (IHECC), aimed at strengthening community-based primary healthcare services, which further increases requirement for medical device coating.

Indias Production Linked Incentive (PLI) Scheme for Medical Devices: India's Production Linked Incentive (PLI) Scheme for Medical Devices aims to enhance domestic manufacturing and attract significant investment in the sector. Launched in 2020, the scheme has a total financial outlay of 3,420 crores, intended to support the growth of the medical devices industry. This initiative has attracted several global players to set up manufacturing units in India, thereby fostering innovation and boosting market growth.

Asia Pacific Medical Device Coating Future Market Outlook

Asia Pacific Medical Device Coating Market is poised for substantial growth over the next five years, driven by the increasing demand for advanced medical devices, the expansion of healthcare infrastructure, and the implementation of supportive government initiatives.

Future Trends

Increased Adoption of Antimicrobial Coatings: The adoption of antimicrobial coatings for medical devices is expected to increase significantly in the Asia Pacific region. This trend will be driven by the growing awareness of hospital-acquired infections (HAIs) and the need to enhance patient safety. Manufacturers will focus on developing coatings that offer superior antimicrobial properties, which can effectively reduce the risk of infections and improve patient outcomes.

Emergence of Smart Coatings for Medical Devices: The development of smart coatings that can provide real-time data on the condition of medical devices is anticipated to be a major trend in the market. These coatings will be integrated with sensors and other technologies to monitor parameters such as device wear, performance, and patient condition. The emergence of such innovative coatings will revolutionize the medical device industry by enabling proactive maintenance and improving device longevity.
Please Note: It will take 5-7 business days to complete the report upon order confirmation